Arjuna Capital Has $1.44 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Arjuna Capital reduced its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 40.9% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 10,464 shares of the company's stock after selling 7,248 shares during the quarter. Arjuna Capital's holdings in Cardinal Health were worth $1,442,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Principal Financial Group Inc. increased its stake in Cardinal Health by 5.3% during the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock valued at $43,510,000 after buying an additional 15,956 shares during the period. Huntington National Bank increased its position in shares of Cardinal Health by 1.2% in the fourth quarter. Huntington National Bank now owns 10,920 shares of the company's stock worth $1,292,000 after acquiring an additional 128 shares in the last quarter. Kingswood Wealth Advisors LLC increased its position in shares of Cardinal Health by 17.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after acquiring an additional 457 shares in the last quarter. Golden State Wealth Management LLC grew its position in Cardinal Health by 569.5% during the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock valued at $54,000 after purchasing an additional 336 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its position in Cardinal Health by 25.8% during the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock valued at $1,811,000 after purchasing an additional 2,694 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently commented on CAH. Evercore ISI reaffirmed an "outperform" rating and set a $180.00 price objective (up from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Wells Fargo & Company raised shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Mizuho lifted their target price on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Wall Street Zen raised Cardinal Health from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 5th. Finally, UBS Group lifted their price objective on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $157.43.

Cardinal Health Price Performance

Shares of CAH stock traded up $0.73 during trading hours on Monday, reaching $161.70. The company had a trading volume of 1,410,382 shares, compared to its average volume of 2,238,154. The company has a 50 day moving average of $157.67 and a 200 day moving average of $139.03. The firm has a market cap of $38.59 billion, a price-to-earnings ratio of 25.23, a P/E/G ratio of 1.59 and a beta of 0.68. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. Cardinal Health's quarterly revenue was up .0% on a year-over-year basis. During the same period last year, the company earned $2.08 earnings per share. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date is Tuesday, July 1st. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is 31.83%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.